- Medical Equipment
EL.En Reports Full Year 2022 Earnings
EL.En (BIT:ELN) Full Year 2022 Results
Key Financial Results
- Revenue: €673.6m (up 18% from FY 2021).
- Net income: €55.1m (up 21% from FY 2021).
- Profit margin: 8.2% (up from 8.0% in FY 2021). The increase in margin was driven by higher revenue.
All figures shown in the chart above are for the trailing 12 month (TTM) period
EL.En Earnings Insights
Looking ahead, revenue is forecast to grow 7.5% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Medical Equipment industry in Europe.
Performance of the market in Italy.
The company's shares are down 16% from a week ago.
It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with EL.En (at least 1 which can't be ignored), and understanding these should be part of your investment process.
Valuation is complex, but we're helping make it simple.
Find out whether EL.En is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.View the Free Analysis
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally.
Good value with adequate balance sheet.